Svmuu News According to , WhiteForest, the former co-founder of Foresight Ventures, has disclosed his entrepreneurial direction for the first time after leaving the company six months ago, and is establishing an agent trading company. He stated that the market mistakenly equates agent trading with "fully autonomous trading." Its core concept is to build an intelligent investment exoskeleton system, where AI is responsible for execution and discipline, amplifying rather than replacing investor capabilities.
WhiteForest co-founded Foresight Ventures and later oversaw core businesses such as token listings and asset management at Bitget, and participated in the acquisition of The Block. He believes that most traders fail because they cannot consistently execute their views, and AI should take on the roles of execution and discipline. He also emphasized that this project needs to address issues such as trust, interaction, and system stability, and that the true advantage lies with enterprises that can efficiently connect machine performance with human nature.
Foresight Ventures former co-founder WhiteForest announces entrepreneurship, establishing an AI agent trading platform
Source:Odaily · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
Billionaire investor Chase Coleman’s Tiger Global fund disclosed in its latest 13F filing that its top five growth stocks are all focused on AI infrastructure, including TSMC, NVIDIA, Amazon, Meta, and Google.
-
2
Will the BEAM token go to zero? Could it rise to $1,000? An in-depth analysis of the Beam network and its market prospects
-
3
What Is CVP? An In-Depth Analysis of the PowerPool Ecosystem and the Investment Value of Its Token, CVP
-
4
Analysis of CRYSTAL’s Value and Investment Potential: An Examination of Multiple Projects and Risk Assessment
-
5
Analysis: The State Street Healthcare ETF (XLV) has an expense ratio of 0.08% and a diversified portfolio, while the Invesco Biotechnology ETF (PBE) has an expense ratio of 0.58% and focuses on small-cap stocks; PBE is up 10.2% year-to-date, outperforming XLV.
-
6
Ethereum Recent Rebound: Price Breaks Above $1,970, but Multiple Risks Remain
-
7
QUARTZ Coin Analysis: An Overview of the Sandclock (QUARTZ) and Unique Network’s Quartz (QTZ) Projects
-
8
What Is JGN? Analysis of the JGN (Sword Saint Coin) Project’s Positioning, Features, and Value
-
9
Iran-linked exchange Shelbit allegedly sent $676 million to Binance in sanctions-evasion operation, Reuters reports
-
10
NVIDIA and AMD: The Two Giants of AI Computing Power in 2026—An Analysis of Market Dynamics, Financial Performance, and Opportunities for Transition into Cryptocurrency Mining
Markets Today
Recommended Reading









